Journal of Current Glaucoma Practice最新文献

{"title":"Urrets–Zavalia Syndrome of Unresolving Mydriasis Following Endocyclophotocoagulation Combined with Phacoemulsification","authors":"Anny M.S. Cheng, Geetha G Vedula, Aarup Kubal, Jillene Moxam, D. T. Yang, Shailesh K Gupta","doi":"10.5005/jp-journals-10078-1431","DOIUrl":"https://doi.org/10.5005/jp-journals-10078-1431","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"52 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140362902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prospective Comparison of VisuALL Virtual Reality Perimetry and Humphrey Automated Perimetry in Glaucoma","authors":"W. E. Sponsel, Jeffrey M Griffin, Grant T Slagle, Truong A Vu, Ainsley Eis","doi":"10.5005/jp-journals-10078-1434","DOIUrl":"https://doi.org/10.5005/jp-journals-10078-1434","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140361461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Rare Case of Postoperative Uveitis and Obstructive Peripheral Anterior Synechiae Following Combined OMNI Canaloplasty and Hydrus Microstent Implantation","authors":"Jella An, Jason Dossantos","doi":"10.5005/jp-journals-10078-1436","DOIUrl":"https://doi.org/10.5005/jp-journals-10078-1436","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"58 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140362472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Outcomes of MicroPulse Transscleral Laser Therapy with the Revised P3 Delivery Device","authors":"S. Dorairaj, Leticia A Checo, Isabella V. Wagner, A. Ahuja","doi":"10.5005/jp-journals-10078-1427","DOIUrl":"https://doi.org/10.5005/jp-journals-10078-1427","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"25 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140362341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Selective Laser Trabeculoplasty on the Fellow Eye","authors":"Matthew Hirabayashi, Elizabeth Mellencamp, Sabrina Duong, Jayce Simoncic, Carlton Homan, Joshua King, Jella An","doi":"10.5005/jp-journals-10078-1420","DOIUrl":"https://doi.org/10.5005/jp-journals-10078-1420","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"9 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139527211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is GATT the Answer?","authors":"Shibal Bhartiya, Zeynep Aktas, Parul Ichhpujani","doi":"10.5005/jp-journals-10078-1425","DOIUrl":"10.5005/jp-journals-10078-1425","url":null,"abstract":"<p><p><b>How to cite this article:</b> Bhartiya S, Aktas Z, Ichhpujani P. Is GATT the Answer? J Curr Glaucoma Pract 2023;17(4):167-168.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 4","pages":"167-168"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aqueous Outflow Facility after Periocular Triamcinolone Injection: A Preliminary Evaluation of the Falck Medical Applanation Tonometer.","authors":"Federico Di Staso, Paul A Gaudio","doi":"10.5005/jp-journals-10078-1421","DOIUrl":"10.5005/jp-journals-10078-1421","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the Falck Medical Applanation Tonometer 1 (FMAT-1) as a device for measuring intraocular pressure (IOP) and outflow facility (OF) in patients with uveitis after periocular triamcinolone injection in one eye.</p><p><strong>Materials and methods: </strong>Retrospective observational comparison. IOP and OF measurements were recorded and analyzed, comparing Goldmann tonometry and FMAT-1 readings. Records were reviewed for adult patients with uveitis who had undergone recent periocular triamcinolone injection in one eye.</p><p><strong>Results: </strong>A total of 19 patients' records were evaluated. In treated eyes, median IOPs (in mm Hg) by Goldmann and FMAT-1 were 21 and 21.0, respectively, and mean IOPs were 22.21 and 21.15, respectively. In untreated eyes, median IOPs by Goldmann and FMAT-1 were 15 and 15.7, respectively, and mean IOPs were 15.52 and 15.31, respectively. Median OF (in µL/mm Hg) in treated and untreated eyes was 0.17 and 0.22, respectively, and mean values were 0.17 and 0.23, respectively. Pearson correlation showed an inverse relationship between IOP and OF in treated eyes, and linear regression analysis showed that IOP strongly predicted outflow in this group.</p><p><strong>Conclusion: </strong>The FMAT-1 generates IOP results substantially similar to Goldmann and OF readings with greater ease than prior tonography devices.</p><p><strong>Clinical significance: </strong>The mechanism of corticosteroid-induced IOP elevation appears to be a reduction in aqueous OF, and its measurement is tonography. This technique has traditionally been cumbersome. FMAT-1 is a newly launched instrument that measures IOP and OF at the slit lamp simultaneously in a few seconds.</p><p><strong>How to cite this article: </strong>Staso FD, Gaudio PA. Aqueous Outflow Facility after Periocular Triamcinolone Injection: A Preliminary Evaluation of the Falck Medical Applanation Tonometer. J Curr Glaucoma Pract 2023;17(4):197-204.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 4","pages":"197-204"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study.","authors":"Andrew Tirsi, Vasiliki Gliagias, Hosam Sheha, Bhakti Patel, Julie Moehringer, Joby Tsai, Rohun Gupta, Stephen A Obstbaum, Celso Tello","doi":"10.5005/jp-journals-10078-1423","DOIUrl":"10.5005/jp-journals-10078-1423","url":null,"abstract":"<p><strong>Aim and background: </strong>To evaluate the ability of pattern electroretinogram (PERG) to detect improvement of retinal ganglion cell (RGC) function in glaucoma suspects (GS) after medically reducing intraocular pressure (IOP) using prostaglandin analog drops.</p><p><strong>Materials and methods: </strong>Six subjects (eight eyes) received topical IOP lowering treatment based on their clinical examination and were observed at Manhattan Eye, Ear & Throat Hospital over an average of 3.1 ± 2.2 months. During this time, participants underwent a full ophthalmologic exam and were evaluated with a Humphrey visual field analyzer (HFA) 24-2 [24-2 mean deviation (MD), 24-2 pattern standard deviation (PSD), and 24-2 visual field indices (VFI)], Diopsys NOVA PERG optimized for glaucoma [magnitude (Mag), magnitudeD (MagD), and magnitudeD/magnitude ratio (MagD/Mag ratio)] and optical coherence tomography (OCT)-derived average retinal nerve fiber layer thickness (avRNFLT) and average ganglion cell layer + inner plexiform layer (avGCL + IPL) thicknesses at baseline visit (pretreatment) and 3 months later (posttreatment). Goldman applanation tonometry was used to measure IOP at each visit. Paired sample <i>t</i>-tests were conducted to determine the statistical significance of the change in IOP, HFA indices, PERG parameters, and OCT thickness measurements between the two visits.</p><p><strong>Results: </strong>Lowering IOP by 22.29% resulted in a significant increase (32.98 and 15.49%) in MagD [<i>t</i> (7) = -3.174, 95% confidence interval (CI) = -0.53, -0.08, <i>p</i> = 0.016] and MagD/Mag ratio [<i>t</i> (7) = -3.233, 95% CI = -0.20, -0.03, <i>p</i> = 0.014], respectively. There was a positive percentage change for all variables of interest, however, 24-2 MD, Mag, avRNFLT, and GCL+ IPLT did not reach statistical significance.</p><p><strong>Conclusion: </strong>After reducing IOP by 22.29% for a duration of 3.1 months, the PERG parameters, MagD and MagD/Mag ratio, significantly improved by 32.98 and 15.49%, respectively.</p><p><strong>Clinical significance: </strong>Pattern electroretinogram (PERG) may be a crucial tool for clinicians to locate a window of opportunity in which degenerating yet viable RGCs could be rescued from irreversible damage. We suggest consideration of PERG as a tool in early retinal ganglion cell (RGC) dysfunction detection as well as for monitoring IOP lowering treatment.</p><p><strong>How to cite this article: </strong>Tirsi A, Gliagias V, Sheha H, <i>et al.</i> Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study. J Curr Glaucoma Pract 2023;17(4):178-190.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 4","pages":"178-190"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Viscodilation of Schlemm's Canal Combined with Goniectomy Using a 30 G Needle (Visco-Bent Ab Interno Needle Goniectomy).","authors":"Tanuj Dada, Nitika Beri, Anin Sethi, Namrata Sharma","doi":"10.5005/jp-journals-10078-1424","DOIUrl":"10.5005/jp-journals-10078-1424","url":null,"abstract":"<p><strong>Background and aim: </strong>Bent ab interno needle goniectomy (BANG) is a low-cost minimally invasive glaucoma surgery (MIGS) technique that has gained wide popularity in developing nations. However, the risk of injury to surrounding angle structures and especially the outer wall of Schlemm's canal (SC) is the main drawback of this technique. We describe a simple and easy-to-perform modification, \"Visco-BANG,\" to improve the safety and efficacy of the BANG procedure.</p><p><strong>Technique: </strong>A 30 gauge (G) needle attached to a syringe filled with cohesive viscoelastic is used. The needle is bent at the proximal junction of the bevel with bevel towards the operating surgeon. The needle is then inserted into the SC and viscoelastic injected to dilate the canal, creating a buffer between the inner and outer walls of SC, which is followed by cutting of a trabecular meshwork (TM) strip.</p><p><strong>Conclusion: </strong>The current modification can prevent damage to adjoining angle structures, including the outer wall of SC, which is critical for aqueous outflow. It can potentially increase efficacy of the BANG procedure by incorporating viscodilation of the SC along with removal of the TM.</p><p><strong>Clinical significance: </strong>Injury to surrounding structures causes a fibrotic response, which is the main cause of failure for the BANG procedure. Prevention of injury to adjoining structures and dilatation of the SC can potentially increase the long-term success rates of this procedure.</p><p><strong>How to cite this article: </strong>Dada T, Beri N, Sethi A, <i>et al.</i> Viscodilation of Schlemm's Canal Combined with Goniectomy Using a 30 G Needle (Visco-Bent Ab Interno Needle Goniectomy). J Curr Glaucoma Pract 2023;17(4):210-213.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 4","pages":"210-213"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139544651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ocular Surface Evaluation after Switch from Latanoprost 0.005% to Latanoprostene Bunod 0.024.","authors":"Virginia Zanutigh, Leila Galetto, Florencia Valvecchia, Celina Logioco","doi":"10.5005/jp-journals-10078-1422","DOIUrl":"10.5005/jp-journals-10078-1422","url":null,"abstract":"<p><strong>Aim and background: </strong>To evaluate the ocular surface of patients treated with latanoprost (LT) 0.005% who switched to latanoprostene bunod (LBN) 0.024%.</p><p><strong>Materials and methods: </strong>A prospective and nonrandomized clinical study of a case series was performed, including patients with chronic open-angle glaucoma who were on previous LT-only treatment and, after a washout period, switched to LBN, with a 3-month follow-up. The main parameter to be evaluated was the ocular surface disease index (OSDI) test. In addition, best-corrected visual acuity (BCVA), intraocular pressure (IOP), biomicroscopic aspect of the ocular surface, measuring tear breakup time, fluorescein staining (grading performed on Oxford scale) and Schirmer I test were evaluated.</p><p><strong>Results: </strong>A total of 36 patients (72 eyes) were included, 21 women (58.3%) and 15 men (41.7%, with a mean age of 65.6 ± 10.9 years (37-86). The initial OSDI score was 17.8 ± 12.1 and improved to 11.1 ± 10.5 (<i>p</i> < 0.01). From the data evaluated at biomicroscopy, an improvement was observed in the Oxford scale from 0.6 ± 0.7 to 0.2 ± 0.8 (<i>p</i>: 0.01), but no statistically significant changes were observed in the break-up time (BUT) and Schirmer. BCVA remained stable, as did IOP, which was initially 13.4 ± 2.1 mm Hg and, after performing the LBN treatment change, went to 13.1 ± 1.7 mm Hg.</p><p><strong>Conclusion: </strong>After the change of treatment from LT 0.005% to LBN 0.024%, the patients had an improvement in the ocular surface, maintaining control of their IOP. The need to investigate possible beneficial mechanisms on the ocular surface in glaucoma patients treated with LBN, potentially related to nitric oxide, is raised.</p><p><strong>Clinical significance: </strong>Patients treated with LT 0.005% who switched to LBN 0.024% had an improvement in ocular surface symptoms and signs, keeping IOP under control.Latanoprostene bunod (LBN) 0.024% may have beneficial effects on the ocular surface, which should be further studied.</p><p><strong>How to cite this article: </strong>Zanutigh V, Galetto L, Valvecchia F, <i>et al.</i> Ocular Surface Evaluation after Switch from Latanoprost 0.005% to Latanoprostene Bunod 0.024%. J Curr Glaucoma Pract 2023;17(4):205-209.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 4","pages":"205-209"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}